Product management is one of the most misunderstood functions in a life sciences or commercial organization. Ask ten people and you will get ten different answers — because the role genuinely varies by industry, company size, and portfolio complexity. But at its core, product management exists to do one thing: own the commercial life of a product from strategy through end-of-life.
This article explains what product management actually does, how it connects to adjacent functions, and why organizations that underinvest in it tend to find out the hard way.
The Core Mandate
Product management sits at the intersection of strategy, science, and market reality. It is responsible for defining what products the organization will build, how they will be positioned, and whether they continue to earn their place in the portfolio.
The primary responsibilities fall into four areas.
Product strategy and roadmap. Product managers define the long-term vision for a product or product family — what the product is, who it serves, how it will evolve, and what investments are required to stay competitive. This roadmap is not a wish list. It is a prioritized, resource-grounded plan that has to survive contact with finance, operations, and market realities.
Portfolio management. Most product managers oversee not one product but a portfolio. That means continuously evaluating which products are performing, which are declining, and which have reached end-of-life. Portfolio decisions require objective financial and market analysis — not emotional attachment to legacy products or sunk-cost reasoning.
Lifecycle management. Products move through a predictable arc: introduction, growth, maturity, decline. Product management is responsible for managing that arc deliberately — timing upgrades and next-generation introductions, deciding when to defend share versus harvest margin, and executing end-of-life in a way that protects customer relationships.
Cross-functional coordination. Product management does not build products alone. It works with R&D and product engineering to shape the technical roadmap, with regulatory and quality teams to ensure compliance, with marketing to develop positioning and launch plans, and with sales to arm commercial teams with the tools and knowledge they need to sell effectively. The product manager is the connective tissue between all of these.
How Product Management Relates to Adjacent Functions
The boundaries between product management and other functions are a frequent source of organizational friction. Understanding who owns what — and where the interfaces are — is essential for a well-functioning product organization.
Product Management owns product strategy, roadmap, portfolio, and lifecycle. It sets direction and aligns all functions to the product vision. Product Engineering and R&D own architecture, technical development, and performance — they translate PM strategy into buildable product specifications. Regulatory and Quality own compliance, submissions, and QMS — they validate that product development meets applicable standards. Marketing owns positioning, messaging, and demand generation — they execute the market strategy PM defines and feed market intelligence back into it. Sales owns customer acquisition and account management — they deliver the value proposition and surface unmet needs from the field.
This is not a hierarchy — it is a set of interdependencies. When these functions are well-aligned, products launch on time, position well, and generate durable revenue. When they are misaligned, organizations discover the problem at launch, which is the worst possible time.
What Product Managers Are Accountable For
Beyond activity-level responsibilities, product managers carry measurable accountability. In a well-structured organization, a product manager should be able to answer the following questions at any point in time: What is the revenue contribution of each product in the portfolio? What is the gross margin profile, and how does it compare to targets? What is the addressable market for each product, and what share does the company hold? Which products are at risk from competition, technology disruption, or regulatory change? What is the product roadmap for the next 12 to 36 months, and what investment is required to execute it?
If a product manager cannot answer these questions with data, the organization has a governance problem, not just a product problem.
Portfolio Thresholds and Exit Criteria
One of the most underappreciated aspects of product management is the discipline of exit. Keeping underperforming products alive is expensive — in manufacturing overhead, inventory, regulatory maintenance, sales attention, and opportunity cost. Effective product managers define explicit thresholds for minimum viable portfolio contribution: revenue floors, margin minimums, and growth rate requirements that, if not met, trigger a structured review.
Products that fall below threshold are assessed against two questions: Can this product be repositioned or reformulated to recover performance? And if not, what is the most orderly path to end-of-life that protects customers and clears capacity for better opportunities?
Exit decisions are never popular. They are almost always correct.
Product Management in Life Sciences and Healthcare
In life sciences, pharmaceutical, and medical device organizations, product management carries additional complexity that most commercial industries do not face. Regulatory approval status governs what can be changed and on what timeline. Label restrictions shape how products can be positioned and promoted. Post-market surveillance obligations create ongoing responsibilities long after launch. And reimbursement dynamics — payer coverage, coding, and pricing pressure — add a financial layer that product managers must understand even if they do not own it directly.
The result is a function that must be commercially sharp, scientifically literate, and regulatory-aware simultaneously. Organizations that hire product managers with only one or two of these competencies tend to find the gaps at the worst moments — a failed launch, a competitive displacement, or a regulatory action they did not see coming.
The Bottom Line
Product management is not a support function. It is a strategic function with direct accountability for one of an organization’s most valuable assets: its product portfolio. When it is staffed and resourced correctly, it drives coordinated growth. When it is underinvested — treated as a liaison role or buried under administrative tasks — organizations tend to find themselves reactive, misaligned, and losing ground to competitors who take it seriously.
MKA Insights works with life sciences and healthcare organizations on product strategy, portfolio rationalization, and commercial planning. Contact us.